PALI

0.83999.24%
RC

Ramesh C. Donthamsetty

Head of IR and Corporate Strategy

Mr. Ramesh C. Donthamsetty, CFA, is Head of IR and Corporate Strategy of Palisade Bio, Inc. from 2026 and was its Head of Corporate Development & Investor Relations from 2026 to 2026 and served as its Senior VP of Corporate Development & Investor Relations since 2026 until 2026. Mr. Donthamsetty was an Analyst at JP Morgan Chase & Co, Research Division. He associated with the firm from August 2010 to March 2013. He has over several years of experience across the life sciences ecosystem, with a unique perspective shaped by his roles as an investor, sell-side analyst and corporate strategist. His background spans capital markets, corporate development and strategic advisory, providing a comprehensive view of value creation across the sector. Prior to joining Palisade Bio, He served as Portfolio Manager at Bioceptive Holdings, a family office focused on life sciences. His experience also includes serving as an advisor to PDL on private credit and royalty investments, as well as several years as a Wall Street analyst at J. P. Morgan, where he covered life sciences tools, diagnostics and medical devices. Earlier in his career, He worked in management consulting at Easton Associates and Extera Partners, advising companies on high-level corporate strategy. He holds Bachelor of Science degrees in Bioengineering and Chemistry from the University of Pennsylvania and is a Chartered Financial Analyst charterholder.

Positions